Baxter Announces Vantive as the Name of Proposed Kidney Care Spinoff
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company…
Merck Announces Phase 3 KEYNOTE-756 Trial Met Primary Endpoint of Pathological Complete Response (pCR) Rate in Patients With High-Risk, Early-Stage ER+/HER2- Breast Cancer
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of its dual primary endpoints of pathological…
Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from two Phase 3 trials evaluating V116, the company’s investigational 21-valent pneumococcal conjugate vaccine in vaccine-naïve and previously vaccinated individuals. If approved,…
CVS Pharmacy introduces new universal tools collection from one+other
Today, on International Self-Care Day, CVS Pharmacy® is expanding its one+other assortment with the new inclusively designed Universal Tools collection to continue its attention to the unique and individual needs of its diverse consumer base. In January 2023, CVS Pharmacy introduced…
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
Pfizer Inc. (NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. Effective today, Chris Boshoff, M.D., PhD, will join Pfizer’s Executive Leadership…
GE HealthCare Reports Second Quarter 2023 Financial Results
GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the second quarter ended June 30, 2023. GE HealthCare President and CEO Peter Arduini said, “We are pleased with organic orders growth of 6% for…
Chemed Reports Second-Quarter 2023 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2023,…
Fisher & Paykel Healthcare Director Donal O’Dwyer to retire, Graham McLean to join the Board as non-executive director
Fisher & Paykel Healthcare Director Donal O’Dwyer has announced his intention to retire as a director of the company with effect from 31 December 2023. The company also announced it has appointed Graham McLean to the Board as a non-executive director…
CENTENE CORPORATION REPORTS SECOND QUARTER 2023 RESULTS
Centene Corporation (NYSE: CNC) (“the Company”) announced today its financial results for the second quarter ended June 30, 2023. In summary, the 2023 second quarter results were as follows: Total revenues (in millions) $ 37,608 Premium and service revenues (in millions)…
Centene’s Texas Subsidiary Announces Successful Reprocurement of STAR+PLUS Contract
Centene Corporation (NYSE: CNC) announced today that its Texas subsidiary, Superior HealthPlan (Superior), will continue to provide the aged, blind and disabled (ABD) population with healthcare coverage through the STAR+PLUS program. A new six-year contract, with a maximum of three additional two-year extensions,…
Siemens Healthineers opens Innovation Center in Erlangen
Siemens Healthineers has opened its new Innovation Center in Erlangen, Germany, in the heart of the regional medical technology research area known as Medical Valley. The focus is on open innovation by collaborating with external partner companies, start-ups and academic…
Global Transcatheter Heart Valve Market Set to Reach $15.14 Billion by 2030 with a Strong CAGR of 12.73% – ResearchAndMarkets.com
The global transcatheter heart valve market is estimated to witness substantial growth, reaching a projected value of US$ 15.14 Billion by 2030 at a robust compound annual growth rate (CAGR) of 12.73% from 2022 to 2030. Key Companies Mentioned: Over…